Thermo Fisher Scientific Inc. (TMO)

• Annual Data
• Quarterly Data

Thermo Fisher Scientific Inc., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders’ Equity

		Dec 31, 2018		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014
	Short-term obligations and current maturities of long-term obligations
	Accounts payable
	Accrued payroll and employee benefits
	Contract liabilities
	Deferred revenue
	Other accrued expenses
	Current liabilities
	Deferred income taxes
	Other long-term liabilities
	Long-term obligations, excluding current maturities
	Long-term liabilities
	Total liabilities
	Preferred stock, $100 par value; none issued
	Common stock, $1 par value
	Capital in excess of par value
	Retained earnings
	Treasury stock at cost
	Accumulated other comprehensive items
	Shareholders’ equity
	Total liabilities and shareholders’ equity

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-28), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-25), 10-K (filing date: 2015-02-26).